Elemental Impurities Analysis

Bespoke Elemental Impurities Analysis services to support you at every stage of product development and manufacture.  

Resolian’s Elemental Analysis team is committed to providing you with the most reliable and comprehensive elemental impurities testing services.

As your partner, Resolian can help ensure the safety and compliance of your products, no matter the complexity of your analytical challenges.

Reach out to us directly to learn more about Resolian’s Elemental Impurities Analysis services.

Services in Detail

Tailored Elemental Impurities Testing: Offering customized limit test based screening methods for your specific sample matrix, dosage route, and daily dose combination.

Versatile Method Development: Developing and validating both quantitative and limit test methods, even for challenging scenarios like high-dose parenterals and complex topical products.

Microwave Digestion and Extraction: Utilizing microwave technology to efficiently digest and extract elements from various sample types.

HF Acid Total Digestion: For comprehensive elemental analysis, Resolian employs HF acid total digestion to ensure no element goes unnoticed.

Simulated Use Extraction: Simulating real-world conditions to assess the potential release of elemental impurities under practical usage scenarios.

Extractable & Leachable Testing: Resolian’s expertise extends to Extractables & Leachables testing to evaluate the impact of container-closure and single-use systems on your product.

Our
Resources

Our Resources

Biomarker Assay List

Bioanalytical LC-MS/MS Assay List 

Immunoassay Pharmacokinetics

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.